BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 20544058)

  • 1. Postmenopausal osteoporosis: another approach to management.
    Cole R
    J Fam Pract; 2010 Jun; 59(6):E1-7. PubMed ID: 20544058
    [No Abstract]   [Full Text] [Related]  

  • 2. Preventing osteoporosis-related fractures: an overview.
    Gass M; Dawson-Hughes B
    Am J Med; 2006 Apr; 119(4 Suppl 1):S3-S11. PubMed ID: 16563939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In postmenopausal women with osteoporosis, is zoledronic acid (Reclast) superior in improving T-scores and decreasing fracture rates when compared with placebo?
    Bilbao J; Pugh A; Aspy CB
    J Okla State Med Assoc; 2010 Aug; 103(8):374-5. PubMed ID: 21049709
    [No Abstract]   [Full Text] [Related]  

  • 4. Postmenopausal osteoporosis.
    Diab DL; Watts NB
    Curr Opin Endocrinol Diabetes Obes; 2013 Dec; 20(6):501-9. PubMed ID: 24150190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimising bisphosphonate treatment outcomes in postmenopausal osteoporosis: review and Italian experience.
    Rossini M; Di Munno O; Gatti D; Giannini S; Minisola S; Varenna M; Adami S
    Clin Exp Rheumatol; 2011; 29(4):728-35. PubMed ID: 21813068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Does ibandronate (Bonviva) have an impact on non-vertebral fractures?].
    Kastelan D; Vlak T
    Reumatizam; 2007; 54(2):87-8. PubMed ID: 18351153
    [No Abstract]   [Full Text] [Related]  

  • 7. [New bone density conservation agents for osteoporosis under research and development: Minodronic acid].
    Takata S
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():417-20. PubMed ID: 18161142
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of postmenopausal osteoporosis in the general medical practice (clinical case)].
    Zhdan VM; Kitura OIe; Kitura IeM; Babanina MIu; Tkachenko MV
    Lik Sprava; 2013 Mar; (2):85-9. PubMed ID: 24605616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Osteoporosis priority: Reduce the number of fractures].
    Roux C
    Presse Med; 2006 Oct; 35(10 Pt 2):1527-8. PubMed ID: 17028516
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug treatment of postmenopausal osteoporosis. What's New in 2006].
    Roux C; Briot K; Dumarcet N; Bourgoin M; Chapurlat R; Christin-Maitre S; Cortet B; Costagliola D; Diebolt V; Lacoin F; Letombe B; Oberlin F; Orcel P; Ravaud P; Seret P; Thomas T; Vogel JY; Barna A; Nouyrigat E; Veyries ML; Yoldjian I
    Presse Med; 2006 Oct; 35(10 Pt 2):1529-39. PubMed ID: 17028517
    [No Abstract]   [Full Text] [Related]  

  • 11. [Absolute risk for fracture and WHO guideline. Selection of drugs for the prevention of fractures in postmenopausal women].
    Gorai I;
    Clin Calcium; 2007 Jul; 17(7):1090-6. PubMed ID: 17607077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ["European Guidance 2008" for the diagnosis and management of postmenopausal osteoporosis--what is new and clinically relevant?].
    Bartl R;
    Dtsch Med Wochenschr; 2009 Jan; 134(3):92-4. PubMed ID: 19142840
    [No Abstract]   [Full Text] [Related]  

  • 13. Ask the doctor. I'm looking for information on Prolia and Reclast as alternatives to Boniva.
    Robb-Nicholson C
    Harv Womens Health Watch; 2011 Nov; 19(3):8. PubMed ID: 22276325
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinician's perspective on the use of zoledronic acid in the treatment of postmenopausal osteoporosis.
    Lewiecki EM
    J Clin Densitom; 2008; 11(4):478-84. PubMed ID: 18757222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of osteoporosis in an active female patient?].
    Fassbender WJ
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2416. PubMed ID: 18988136
    [No Abstract]   [Full Text] [Related]  

  • 16. [Expert group consensus: prevention, diagnosis and treatment of bone loss and osteoporosis in postmenopausal breast cancer patients after aromatase inhibitor therapy].
    Xiu Bing-He ;
    Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):876-9. PubMed ID: 24447490
    [No Abstract]   [Full Text] [Related]  

  • 17. [Osteoporosis].
    Pfeilschifter J
    MMW Fortschr Med; 2004 Mar; 146(11):61, 63. PubMed ID: 15152780
    [No Abstract]   [Full Text] [Related]  

  • 18. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of women at risk for fracture and intervention with fast-acting therapies.
    Derman R
    Int J Fertil Womens Med; 2006; 51(4):183-90. PubMed ID: 17184104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Under-use of bisphosphonates in rural elderly women who have sustained fractures.
    Naunton M; Peterson G; Jones G
    Aust J Rural Health; 2006 Dec; 14(6):286. PubMed ID: 17121511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.